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Summary When human melanoma cells are injected into nude mice they usually give rise to tumours that
grow progressively and do not elicit a prominent host response. We have recently developed a melanoma cell
line, UCT-Mel 7, that did not show these characteristics.
In the first place UCT-Mel 7 showed a consistently unusual, phasic growth pattern. After a short initial
period of limited growth (phase 1), the tumour ceased growing and remained static for 2-3 months (phase 2).
The tumour then regressed (phase 3) to enter a second period of quiescence (phase 4) which was eventually
broken by the emergence of a rapidly growing lethal tumour (phase 5).
Of particular interest was the fact that the rate at which the tumours grew correlated closely with their
collagen content. During the prolonged, phase 2 plateau, the tumours were intensely desmoplastic; rapidly
growing phase 5 tumours, that had escaped from dormancy, contained very little collagen and virtually no
reticulin.
This cell line helps to fill an important need for an experimental system for the study of desmoplasia,
dormancy and progression.
Solid tumours growing in vivo comprise two distinct com-
ponents. The first of these is made up of neoplastic cells
while the second is the complex supporting stroma that
consists of mesenchymal cells and the various macro-
molecular structural elements that characterise connective tis-
sues (Robbins et al., 1984).
The amount of stroma varies from one tumour to another.
In anaplastic carcinomas and sarcomas it is usually scanty
and devoid of recognisable structure, whereas in most well-
differentiated malignant tumours and in benign tumours, the
stroma is moderate and ordered. One also encounters a third
category of neoplasms, such as the scirrhous carcinomas,
where the stroma is so abundant and dense that it contri-
butes substantially to the mass of the tumour (Willis, 1967).
The development of fibrous stromal tissue within and around
a tumour is referred to as desmoplasia (Liotta, 1982; Rob-
bins et al., 1984) and it is generally believed that the desmo-
plastic response reflects the host mesenchymal reaction to the
presence of neoplastic cells.
Although desmoplastic tumours are commonly encountered
clinically, the significance of the fibrous tissue response is
uncertain. It is not known, for example, if desmoplasia and
the tumour phenotype are related in the sense that the
mesenchymal reaction influences tumour growth and spread
or, alternatively, if it is simply a characteristic of certain
tumours that they are fibrogenic and that this association has
no bearing upon prognosis.
Since few in vivo experimental systems are available for the
investigation of these tissues we feel it appropriate to report
the characteristics of a human malignant cell line, UCT-
Mel 7, that we have recently established in our laboratory.
When cells from this line are inoculated into nude mice,
tumours develop that are intensely desmoplastic and that
show growth kinetics that differ from those of other
melanoma xenografts that do not induce desmoplasia. In this
paper we describe these UCT-Mel 7 derived tumours and
draw attention to their value as a useful experimental model
for the study of dormancy and of mesenchymal host reac-
tions to the presence of neoplastic cells.
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Materials and methods
Cell lines
The six melanoma cell lines (UCT-Mel 1-5 and UCT-Mel 7)
used in this study were developed in this laboratory from
biopsy material obtained at Groote Schuur Hospital. Their
characteristics have previously been described in detail (Wil-
son et al., 1984; Hoal-van Helden et al., 1986; Wilson et al.,
1988). The line of particular interest, UCT-Mel 7, was estab-
lished from a biopsy of a femoral lymph node metastasis that
developed in a 52-year-old woman who presented with a
malignant melanoma, Clark's level V, of the left heel. Histo-
logical examination of the biopsy sample showed a non-
pigmented secondary malignant melanoma with spindle cell
morphology. The cell line grew in culture as an adherent
monolayer of spindle-shaped cells.
Nude mice
Mice of the N-NIH(S)II nu/nu strain (Azar et al., 1980) were
reared from stocks generously provided by Dr B. Giovanella,
Houston, Texas, and were maintained under sterile condi-
tions. For the experiments we used 8-12-week-old progeny
of nu/+ mothers and nu/nu fathers.
Inoculation into nude mice
Melanoma cells were released from the culture vessels with
0.25% trypsin and 0.02% EDTA in Tris-buffered saline
(0.14 M NaCl, 5 mm KCI, 0.7 mm Na phosphate, 25 mM
Tris-HCI; pH 7.4) and immediately resuspended in RPMI-
1640 containing 10% fetal calf serum. The cells were pelleted,
resuspended in serum-free RPMI-1640 at a concentration
such that the desired inoculum (usually 1 to 5 x 106 cells) was
contained in 0.1 ml, and injected subcutaneously between the
scapulas. Direct passage of tumours from one animal to
another was accomplished by implanting small fragments of
the tumour into the subcutaneous tissues. Mice were
examined and their tumours were measured weekly. The
technique used for transfer (i.e. as cells or as fragments) had
no obvious effect upon in vivo growth kinetics of the tumours
that subsequently developed. Tumour volumes were cal-
culated as the products of three major diameters.
Examination oftumours
Tumours were removed and divided into representative por-
tions for histology, passage in vivo or biochemical analysis.
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Formalin-fixed samples were embedded in paraffin, sectioned
and stained according to standard histological techniques.
Sections of the tumours were stained for reticulin according
to the method of Gordon & Sweets (1936).
The hydroxyproline content of the tumours was deter-
mined colorimetrically using the method of Hutterer & Singer
(1960) in which tissues were hydrolysed in 6 N HCl, dried in
vacuo and the residue dissolved in distilled water. The
absorbance was read at 500 nm and 560 nm, after adding
p-dimethylaminobenzaldehyde, and referred to a hydroxy-
proline standard curve.
Results
Growth characteristics of UCT-Mel 7-derived tumours
It has been our consistent experience that inocula of malig-
nant melanoma cells typically give rise to tumours that
develop shortly after inoculation and that grow relentlessly
and exponentially thereafter.
UCT-Mel 7 cells grew differently (Figure 1). In most cases
five distinct sequential phases could be discerned:
1. a period of early latency followed by a short period of
exponential growth that lasted approximately 10 days.
2. This was followed by a plateau phase during which the
size of the tumour remained constant. This lasted for 70-100
days.
3. A phase of regression then ensued, during which time
the tumour diminished in size, frequently becoming barely
perceptible.
4. This was followed by a period of dormancy which was
broken, by now 4-7 months after inoculation, by
5. a phase of aggressive, exponential growth.
Not all tumours showed all five phases of growth. In some,
rapid exponential growth (phase 5) followed a short period
of regression without the quiescent phase 4 (Figure lb). Once
the tumours had entered phase 5 they all grew with remark-
ably similar growth kinetics. If they were removed at this
stage and reimplanted into fresh recipients the tumours that
resulted grew exponentially without a dormant phase and
with similar in vivo doubling times (mean of 30 tumours = 10
days; range 5-12 days; s.e.m. 0.5 days (data not shown).
E
E
0
E I-
Collagen content of UCT-Mel 7-derived tumours
The well-defined and circumscribed tumours that developed
at the site of inoculation were excised during phase 2 and
their collagen content was measured as hydroxyproline pre-
sent in tumour lysates. UCT-Mel 7 tumours contained an
average of 67.6 pg (± 9.5 s.e.m.) hydroxyproline per mg of
cellular protein. The average hydroxyproline content of the
other melanomas examined ranged from 2.4-4.5 lAgmg-l cel-
lular protein (Figure 2). UCT-Mel 7 was, therefore, unique in
inducing a desmoplastic response. Despite the intense fibrotic
response within the tumour, the mass was readily separable
from adjacent normal tissues that showed remarkably little
mesenchymal reaction to the melanoma xenograft.
The collagen content of UCT-Mel 7 tumours varied with
the phase of growth. As stated above, tumours removed
during phase 2 had a hydroxyproline content of 67.6 ± 9.5 pg
mg-' cellular protein, whereas the hydroxyproline content of
phase 5 tumours and phase 5 tumours that had been
passaged in vivo was negligible (1.1 ± 0.6 and 1.0 ± 0.4 jig
mg-' cellular protein, respectively) and not significantly
different from that of tumours derived from UCT-Mel 1-5
(Figure 2).
Histological appearances of UCT-Mel 7-derived tumours
The histological appearance of the UCT-Mel 7-derived
tumours at different phases are shown in Figure 3. Tumours
removed during phase 2 were well differentiated tumours
composed of spindle shaped melanoma cells embedded in a
dense fibrous stroma. Silver staining revealed an abundant
reticulin network that surrounded individual tumour cells.
Tumours removed during phase 5, although less obviously
differentiated, still retained their spindle shaped morphology.
Collagen deposition and reticulin fibre formation were vir-
tually absent.
Discussion
The tumours that developed when UCT-Mel 7 cells were
inoculated into nude mice were consistently unusual in that
they started as slowly growing or dormant tumours that
Days after inoculation
Figure 1 Growth of UCT-Mel 7 cells in nude mice. Mice received subcutaneous inocula of 5 x 106 UCT-Mel 7 cells on day 0.
Tumour volumes were measured at the indicated times and data from a single mouse are plotted as a function of time in each of
parts a-d. The first timepoint was taken after 10 days by which time the tumours had already reached plateau volume. For this
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Figure 2 Collagen content ofdifferent human melanomas (desig-
nated UCT-Mel 1-5 and UCT-Mel 7) excised from nude mice.
Tumours were excised, hydrolysed and assayed for protein and
collagen content as described in the Methods section. Bar heights
represent the average hydroxyproline contents for the number of
tumours indicated. Error bars represent 1 s.e.m. Tumours derived
from cell lines UCT-Mel 1-5 were assayed during the period of
exponential growth (usually 30 days after inoculation when
tumours weighed between 0.5 and 1 g). The subcripts to the UCT
Mel-7 labels indicate tumours excised during phase 2(2); tumours
excised during phase 5(5); or exponentially growing tumours
derived from re-implanted fragments of phase 5 tumours (5p).
elicited an intense fibrogenic response and subsequently pro-
gressed to become rapidly growing tumours that were not
desmoplastic.
In a sense this corresponds with a teleological view of
desmoplasia that sees the response as an attempt by the host
to 'wall off' the tumour both physically and immunologically
(Liotta, 1982). But whether, as is implied by this view, the
desmoplastic response is beneficial to the host is debatable.
Desmoplasia has been variously associated with an adverse
(Cantin et al., 1982; Halvorsen & Seim, 1989) or a favourable
(Seemayer et al., 1980) prognosis for growth and spread of
the tumour.
Our observations have shown that the apparent quiescence
that was associated with desmoplasia was invariably ter-
minated by an alteration in the innate characteristics of the
restrained cells which progressed to develop into the rapidly
growing tumours seen in phase 5. The new phenotype was
stable since passage into fresh recipients gave rise to tumours
with similar characteristics and with neither the dormant nor
the desmoplastic features of the original xenografts.
It is one of the characteristics of tumour progression that
tumour cell populations increase their growth rate. This is
not due to a shortening of the cell cycle time but rather to
progressive mutations that lead to an increase in that popul-
tion of cells within the tumour whose proliferation is no
longer balanced by terminal differentiation or cell death
(Nowell, 1986). If one accepts this view our observations
would suggest a complex interaction between host and
tumour in which asymmetrical division (Burgess & Nicola,
1983) of a small number of stem cells in the original xeno-
Figure 3 Histological sections of UCT-Mel 7-derived tumours at different growth phases. The sections were stained with
haematoxylin and eosin (a and b) or to show reticulin (c and d). Appearances of tumours removed during the plateau phase (phase
2) are shown in a and c. Tumours removed during phase 5 are shown in b and d.
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graft gave rise to two daughter cell populations - one with
the capacity for self renewal and the other, a transit cell
population, with limited proliferative potential, a commit-
ment to terminal differentiation and the ability to evoke a
desmoplastic response.
The dramatic escape, from the quiescent state of equili-
brium between renewal divisions and maturation divisions to
the aggressive state where rate of renewal exceeded the rate
of maturation and death, may have been due to genetic
changes in a stem cell or in a transit cell. We have, as yet, no
evidence to indicate which of these two cell types was targeted
for progression. The effect, nevertheless, was to generate a
cell line that no longer induced collagen deposition.
The intensity of the fibrosis raises two questions: the first
relating to the nature of the fibrogenic signal and the second
to the significance of the stromal response.
It is known that cytokines such as transforming growth
factor beta (TGF-,B) are capable of inducing collagen syn-
thesis (Ignotz et al., 1987; Raghow et al., 1987; Roberts et
al., 1988) and basic fibroblast growth factor (bFGF) is
known to be elaborated by melanoma cells (Halaban et al.,
1988; Becker et al., 1989) and to stimulate fibroblast pro-
liferation (Gospodarowicz, 1987). Experiments to assess the
role of these mediators in our system are currently in pro-
gress.
As far as the significance of the desmoplastic reaction is
concerned a number of possibilities exist. The stroma, by
mediating cellular interactions with growth factors (Vlodavsky
et al., 1987; Roberts et al., 1988; Saksela et al., 1988) may
have exerted indirect differentiation pressures upon the
tumour cells to maintain asymmetric division; alternatively
the fibrosis may have been an epi-phenomenon with no effect
upon the phenotype. With this model, these possibilities are
now testable.
There appears to be only one other animal model that
might be used to address the important issues that concern
desmoplasia. This was described by Barsky & Gopalakrishna
(1987) who found that BL6 mouse melanoma cells inoculated
into 18-month-old C57BL/6 mice elicited a desmoplastic re-
sponse that could be inhibited by the administration of L-3,4-
dehydroproline. In their model, the induction of desmoplasia
was age-dependent since it was seen only in 18-month-old
mice; tumours in 6-week-old-mice were not fibrotic. In our
system the induction of a fibrous response was determined by
the cell line used and should provide a useful means of
defining host:tumour relationships that are independent of
age and that have relevance to the human clinical situation.
In conclusion, we would stress that, by measuring collagen
content of the tumours, we have examined only one compon-
ent of the highly complex assembly of macromolecules that
constitute the extracellular matrix (for review see Labat-
Robert et al., 1990). We are currently applying our model to
the study of elastin, proteoglycan and structural glycoprotein
metabolism in desmoplasia.
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